Rob W. Armstrong
Vorstandsvorsitzender bei Artax Biopharma, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Lawrence Husick | M | - |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | 15 Jahre |
Edwin R. Addison | M | - |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | 15 Jahre |
Carulla Tormo | M | - |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | - |
Shahar Keinan | M | - |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | 15 Jahre |
John Kozarich | M | 74 |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | 5 Jahre |
Andre Hoekema | M | 67 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 1 Jahre |
Alan Walts | M | 64 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 7 Jahre |
Rich Armstrong | M | - |
Minden Exchange Bank & Trust Co.
Minden Exchange Bank & Trust Co. Regional BanksFinance Minden Exchange Bank & Trust Co. operates as a state chartered commercial bank. Its services include automated teller machine and debit cards, online and mobile banking, exchange bill pay, trust services, direct deposit, notary services, night deposit, coin counting, wire, automatic and telephone transfers, and cashiers check. It offers checking, savings, money market, loans, certificates of deposit, and individual retirement account. The company was founded in September 1, 1883 and is headquartered in Minden, NE. | - |
Andrew Miller | M | 42 |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | 11 Jahre |
Joseph Sorenson | M | - |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | - |
Fan Cheong Chan | M | 72 |
University of California, Los Angeles
| 38 Jahre |
Andres Gagete | M | - |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | - |
Todd Kinard | M | - |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | - |
James S. Economou | M | - |
University of California, Los Angeles
| 38 Jahre |
Brittany Zubrod | F | - |
Minden Exchange Bank & Trust Co.
Minden Exchange Bank & Trust Co. Regional BanksFinance Minden Exchange Bank & Trust Co. operates as a state chartered commercial bank. Its services include automated teller machine and debit cards, online and mobile banking, exchange bill pay, trust services, direct deposit, notary services, night deposit, coin counting, wire, automatic and telephone transfers, and cashiers check. It offers checking, savings, money market, loans, certificates of deposit, and individual retirement account. The company was founded in September 1, 1883 and is headquartered in Minden, NE. | - |
Jeff D. Davis | M | 62 |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | - |
John Villasenor | M | - |
University of California, Los Angeles
| 32 Jahre |
Michael Sikora | M | - |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | - |
Tracey McCormack | F | - |
University of California, Los Angeles
| 31 Jahre |
David Lewin | M | 80 |
University of California, Los Angeles
| 34 Jahre |
James Clarke | M | 51 |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | - |
Lyle S. Lohmeyer | M | - |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | 9 Jahre |
Michael Leavitt | M | 73 |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Curza Global LLC engages in operation of a small-molecule therapeutics firm. It develops several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. The company is headquartered in Salt Lake City, UT. | - |
Andrew Dahlem | M | 64 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | 21 Jahre |
Michael J. Brennan | M | 66 |
Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cloud Pharmaceuticals, Inc. engages in computational discovery, design and development of new drugs and therapies. Its proprietary design process combines artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company was founded by Edwin R. Addison, Lawrence Husick and Shahar Keinan in 2009 and is headquartered in Research Triangle Park, NC. | - |
Thomas Verhoeven | M | - |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | 21 Jahre |
Marisa E. Pratt | F | 59 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | 18 Jahre |
Robert Langer | M | 74 |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | - |
Stephen B. Howell | M | 79 |
University of California San Diego
| 47 Jahre |
Daniel Geffken | M | 67 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | - |
David Silver | M | 58 |
University of California, Los Angeles
| 31 Jahre |
Howard Rosen | M | 66 |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | - |
Gino Santini | M | 67 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 10 Jahre |
Daniel Bonner | M | - |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michael J. Shearer | M | - |
University of California, Los Angeles
| 10 Jahre |
Kathryn Falberg | F | 63 | 6 Jahre | |
Madhavan Balachandran | M | 73 | 20 Jahre | |
Marc M. P. de Garidel | M | 66 | 15 Jahre | |
Joseph Lobacki | M | 65 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | 4 Jahre |
Marc Junkunc | M | - |
University of California, Los Angeles
| 13 Jahre |
Joshua A. Dean | M | - |
University of California, Los Angeles
| 7 Jahre |
Iain Lo | M | 62 |
University of California, Los Angeles
| 5 Jahre |
Patrick H. Hu | M | - |
University of California, Los Angeles
| 7 Jahre |
Paul R. Daza | M | 62 |
University of California, Los Angeles
| 7 Jahre |
John Josey | M | 63 |
Colorado State University
| 8 Jahre |
Kenneth T. Shimizu | M | - |
University of California, Los Angeles
| 8 Jahre |
Kent Douglas Daniel | M | - |
University of California, Los Angeles
| 6 Jahre |
Frans Gustaf Wuite | M | 64 | - | |
Marshall Davert | M | - |
University of California, Los Angeles
| 3 Jahre |
Neil Bodick | M | 77 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | 7 Jahre |
Xingping Charles Yang | M | 62 |
University of California, Los Angeles
| 3 Jahre |
Jerry D. Choate | M | 86 | - | |
Diana McKenzie | F | 59 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | 17 Jahre |
Xue Feng Qian | M | 62 |
University of California, Los Angeles
| 4 Jahre |
Justin M. Sobaje | M | - |
University of California, Los Angeles
| 5 Jahre |
Muhammad Sirajuddin Syamsuddin | M | 64 |
University of California, Los Angeles
| 4 Jahre |
Karen Malmuth Kaufmann | M | - |
University of California, Los Angeles
| 5 Jahre |
Mee Yee Chan | M | 62 |
University of California San Diego
| 5 Jahre |
Chia Soo | M | - |
University of California, Los Angeles
| 8 Jahre |
Donald Jones | M | - |
University of California San Diego
| 5 Jahre |
Ernesto Cervera | M | 66 |
University of California, Los Angeles
| 2 Jahre |
Andrei Iancu | M | - |
University of California, Los Angeles
| 5 Jahre |
Patricia A. Turney | F | 57 | 23 Jahre | |
Geng Xiao | M | 61 |
University of California, Los Angeles
| 5 Jahre |
Larry Larson | M | - |
University of California, Los Angeles
| 7 Jahre |
John G. Adair | M | - |
Colorado State University
| 11 Jahre |
Hiep Nguyen | M | - |
University of California, Los Angeles
| 5 Jahre |
John Smither | M | 71 | 6 Jahre | |
Montague Yort | M | 60 |
University of California, Los Angeles
| 10 Jahre |
Robert Fitzgerald | M | 60 |
University of California, Los Angeles
| 7 Jahre |
Frederick Gluck | M | 88 | 13 Jahre | |
David Baltimore | M | 86 | 21 Jahre | |
Judith C. Pelham | F | 78 | 22 Jahre | |
Glen Y. Sato | M | 65 |
University of California, Los Angeles
| 3 Jahre |
John N. Bonfiglio | M | 69 |
University of California San Diego
| 3 Jahre |
Andrew Evan Shapiro | M | 63 |
University of California, Los Angeles
| 4 Jahre |
Timothy Franson | M | 72 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | 20 Jahre |
Elemer Piros | M | - |
University of California, Los Angeles
| 8 Jahre |
Thirumalai M. Ravi | M | - |
University of California, Los Angeles
| 7 Jahre |
David Lucchino | M | 56 |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | 2 Jahre |
Kevin Andrew Frankel | M | - |
University of California, Los Angeles
| 7 Jahre |
Martin Simonetti | M | 66 | 7 Jahre | |
Winn Hong | M | 54 |
University of California, Los Angeles
| 6 Jahre |
Dan Beaney | M | - |
University of California, Los Angeles
| 5 Jahre |
Matt MacKenzie | M | - |
University of California, Los Angeles
| 7 Jahre |
Robert P. Vogels | M | 66 |
Colorado State University
| 6 Jahre |
Susan Lewis | M | - |
University of California, Los Angeles
| 5 Jahre |
Lawrence W. Shea | M | - |
University of California San Diego
| 4 Jahre |
David L. Bauer | M | 64 |
University of California San Diego
| 4 Jahre |
Timothy Knowles | M | 78 |
University of California San Diego
| 3 Jahre |
Sanford Zweifach | M | 68 |
University of California San Diego
| 4 Jahre |
Tim Todaro | M | - |
University of California San Diego
| 4 Jahre |
Andreas Plückthun | M | 65 |
University of California San Diego
| 3 Jahre |
Ronald S. Bell | M | 58 |
University of California, Los Angeles
| 4 Jahre |
Joseph Edelman | M | 67 |
University of California San Diego
| 4 Jahre |
Steven David Smith | M | 65 |
University of California San Diego
| 4 Jahre |
Chia Wei Woo | M | 87 |
University of California San Diego
| 4 Jahre |
Jeff J. Jeon | M | - |
University of California, Los Angeles
| 3 Jahre |
Greg Harriman | M | - |
University of California San Diego
| 4 Jahre |
Claudette G. Wilson | F | - |
University of California San Diego
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Rob W. Armstrong
- Persönliches Netzwerk